Table of Contents

company-logo

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.

CureVac Dividend Announcement

• CureVac does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on CureVac dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

CureVac Dividend History

CureVac Dividend Yield

CureVac current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing CureVac stock? Use our calculator to estimate your expected dividend yield:

CureVac Financial Ratios

P/E ratio-2.06
PEG ratio-0.07
P/B ratio1.51
ROE-56.86%
Payout ratio0.00%
Current ratio2.29
Quick ratio2.28
Cash Ratio1.84

CureVac Dividend FAQ

Does CureVac stock pay dividends?
CureVac does not currently pay dividends to its shareholders.
Has CureVac ever paid a dividend?
No, CureVac has no a history of paying dividends to its shareholders. CureVac is not known for its dividend payments.
Why doesn't CureVac pay dividends?
There are several potential reasons why CureVac would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will CureVac ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While CureVac has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is CureVac a dividend aristocrat?
CureVac is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is CureVac a dividend king?
CureVac is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is CureVac a dividend stock?
No, CureVac is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy CureVac stocks?
To buy CureVac you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy CureVac stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.